Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

Description

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Clinical A/Prof Lauren Sanders

Clinical A/Prof Lauren Sanders

Migraine Management Update

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases – When to Use Dual vs Triple Therapy

Dr Johanna Lynch

Dr Johanna Lynch

Trauma-Informed Care in GP

Prof Richard O'Brien

Prof Richard O'Brien

Prevention and Management of Diabetic Retinopathy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Peter Richmond

expert

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases

Date published: 21 June 2022